Medicare Enrolled
Dr. Virginia Kinsella, MD
Hematology & Oncology · Plano, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kinsella from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kinsella? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kinsella
Dr. Virginia Kinsella is a hematology & oncology in Plano, TX, with 20 years in practice. Based on federal Medicare data, Dr. Kinsella performed 44,197 Medicare services across 1,785 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kinsella received a total of $12,905 from 61 pharmaceutical and/or device companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kinsella is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 22% volume in TX$ $12,905 industry payments
Medicare Practice Summary
Medicare Utilization ↗44,197
Medicare services
Top 22% in TX for hematology & oncology
1,785
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,210 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 17,100 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 7,575 | $2 | $20 |
| Pembrolizumab injection (Keytruda) | 6,000 | $43 | $137 |
| Contrast dye for imaging (iodine-based) | 2,690 | $0 | $3 |
| Paclitaxel chemotherapy injection | 2,156 | $0 | $8 |
| Immune globulin infusion (Octagam) | 2,140 | $33 | $234 |
| Dexamethasone injection (steroid) | 998 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 840 | $18 | $66 |
| Injection, granisetron hydrochloride, 100 mcg | 740 | $0 | $24 |
| Blood draw (venipuncture) | 376 | $8 | $20 |
| Office visit, established patient (30-39 min) | 370 | $89 | $368 |
| Comprehensive metabolic blood panel | 348 | $10 | $64 |
| Complete blood count (CBC) with differential | 326 | $8 | $36 |
| Injection of additional new drug or substance into vein | 291 | $12 | $108 |
| Anti-nausea injection (Aloxi/palonosetron) | 270 | $1 | $114 |
| Ferritin level test (iron stores) | 198 | $13 | $60 |
| Administration of chemotherapy into vein, 1 hour or less | 198 | $98 | $707 |
| Iron level test | 187 | $6 | $27 |
| Iron binding capacity test | 187 | $9 | $35 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 137 | $48 | $313 |
| Injection, carboplatin, 50 mg | 98 | $2 | $300 |
| Drug injection, under skin or into muscle | 96 | $11 | $96 |
| Injection, diphenhydramine hcl, up to 50 mg | 68 | $1 | $7 |
| Administration of chemotherapy into vein, each additional hour | 60 | $21 | $161 |
| Infusion, normal saline solution , 1000 cc | 59 | $2 | $19 |
| Lactate dehydrogenase (enzyme) level | 56 | $6 | $31 |
| Microscopic examination for white blood cells with manual cell count | 54 | $4 | $22 |
| Complete blood count (CBC), automated | 54 | $6 | $34 |
| Administration of additional new drug or substance into vein, 1 hour or less | 53 | $49 | $344 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 50 | $15 | $100 |
| Unclassified drugs | 50 | $1 | $8 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 48 | $22 | $157 |
| Infusion into a vein for hydration, each additional hour | 39 | $9 | $75 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 39 | $55 | $211 |
| Reticulated (young) platelet measurement | 30 | $35 | $143 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 29 | $20 | $128 |
| Ct scan of chest with contrast | 26 | $44 | $821 |
| CT scan of abdomen and pelvis with contrast | 25 | $168 | $1,067 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 21 | $90 | $657 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 20 | $1,113 | $4,802 |
| Infusion into a vein for hydration, 31-60 minutes | 20 | $25 | $256 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 18 | $15 | $94 |
| CT scan of chest, without contrast | 16 | $37 | $686 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 16 | $352 | $1,722 |
| Drawing of blood for a medical problem | 14 | $62 | $264 |
| Ct scan of abdomen and pelvis without contrast | 11 | $74 | $560 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.7% high complexity
89.0% medium
5.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,905
Total received (2018-2024)
Avg $1,844/year across 7 years
Top 27% in TX for hematology & oncology
61
Companies
286
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,729 (52.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,150 (47.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,936
2023$2,561
2022$2,802
2021$187
2020$74
2019$65
2018$5,279
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$5,608
BeiGene USA, Inc.
$1,021
Merck Sharp & Dohme LLC
$454
AstraZeneca Pharmaceuticals LP
$391
ABBVIE INC.
$292
Pharmacyclics LLC, An AbbVie Company
$290
E.R. Squibb & Sons, L.L.C.
$265
Sirtex Medical Inc
$257
Janssen Biotech, Inc.
$254
Daiichi Sankyo Inc.
$244
GlaxoSmithKline, LLC.
$229
Rigel Pharmaceuticals, Inc.
$225
PFIZER INC.
$219
Gilead Sciences, Inc.
$217
SOBI, INC
$209
Kite Pharma, Inc.
$161
Amgen Inc.
$148
Celgene Corporation
$134
GENZYME CORPORATION
$134
PUMA BIOTECHNOLOGY, INC.
$130
Incyte Corporation
$121
Stemline Therapeutics Inc.
$121
Sobi, Inc
$114
EMD Serono, Inc.
$105
Seagen Inc.
$103
Genentech USA, Inc.
$97
Eisai Inc.
$84
Takeda Pharmaceuticals U.S.A., Inc.
$76
Blueprint Medicines Corporation
$72
Regeneron Healthcare Solutions, Inc.
$69
CTI BioPharma Corp.
$68
Jazz Pharmaceuticals Inc.
$61
G1 Therapeutics, Inc.
$56
Bayer Healthcare Pharmaceuticals Inc.
$56
Puma Biotechnology, Inc.
$55
AVEO Pharmaceuticals, Inc.
$54
Mirati Therapeutics, Inc.
$47
Karyopharm Therapeutics Inc.
$46
Lilly USA, LLC
$41
RECORDATI_RARE_DISEASES_INC.
$41
Apellis Pharmaceuticals, Inc.
$41
EISAI INC.
$39
Pharmacyclics LLC, an AbbVie Company
$38
PharmaEssentia USA Corporation
$35
Epizyme, Inc.,
$34
Genmab U.S., Inc.
$32
Aveo Pharmaceuticals, Inc.
$30
Exelixis Inc.
$28
EUSA Pharma (US) LLC
$27
SERVIER PHARMACEUTICALS LLC
$24
Sumitomo Pharma America, Inc.
$23
Pharmacosmos Therapeutics Inc.
$22
GE HealthCare
$21
Iovance Biotherapeutics, Inc.
$20
Medtronic USA, Inc.
$20
Ipsen Biopharmaceuticals, Inc
$20
Taiho Oncology, Inc.
$18
ADC Therapeutics America, Inc.
$17
Kyowa Kirin, Inc.
$17
Astellas Pharma US Inc
$15
Coherus Biosciences Inc.
$13
Top 3 companies account for 54.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Amtagvi · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · CARVYKTI · COSELA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LOCAMETZ · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NERLYNX · Nplate · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · Phesgo · Pomalyst · Poteligeo · REBLOZYL · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SYLVANT · Stivarga · Sylvant · TABRECTA · TAZVERIK · TECVAYLI · TEPMETKO · TUKYSA · Tavalisse · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VONJO · Vonjo · Voranigo · XPOVIO · XTANDI · Yescarta · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (52%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $29 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
125
Per 100K population
11.2
County median income
$117,588
Nearest hospital
MEDICAL CITY PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kinsella is a mixed practice specialist, with above-average Medicare volume (top 22% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kinsella experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Kinsella performed 17,100 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kinsella receive payments from pharmaceutical companies?
Yes. Dr. Kinsella received a total of $12,905 from 61 companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kinsella's costs compare to other hematology & oncologys in Plano?
Dr. Kinsella's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kinsella) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Plano
Browse hematology & oncologys in Plano ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc..
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology